CAR T-cell therapy, new drugs ushering in ‘lupus renaissance’

SCOTTSDALE, Ariz. — Several new drugs and promising therapies, including chimeric antigen receptor T-cell therapy, have ushered in a “lupus renaissance,” said a speaker at the Basic and Clinical Immunology for the Busy Clinician symposium.
According to Emily Littlejohn, DO, MPH, of the Cleveland Clinic, other potential therapies for systemic lupus erythematosus that have emerged since 2020 include monoclonal antibodies and interferons.
“2020 is what many of us consider the lupus renaissance,” Littlejohn told attendees during the hybrid meeting. “This is a

SCOTTSDALE, Ariz. — Several new drugs and promising therapies, including chimeric antigen receptor T-cell therapy, have ushered in a “lupus renaissance,” said a speaker at the Basic and Clinical Immunology for the Busy Clinician symposium.
According to Emily Littlejohn, DO, MPH, of the Cleveland Clinic, other potential therapies for systemic lupus erythematosus that have emerged since 2020 include monoclonal antibodies and interferons.
“2020 is what many of us consider the lupus renaissance,” Littlejohn told attendees during the hybrid meeting. “This is a